1,078
Views
20
CrossRef citations to date
0
Altmetric
Research Article

Co-infusion of donor adipose tissue-derived mesenchymal and hematopoietic stem cells helps safe minimization of immunosuppression in renal transplantation – single center experience

, , , , , , , & show all
Pages 1376-1384 | Received 06 Mar 2014, Accepted 30 Jul 2014, Published online: 23 Sep 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Franka Luk, Samantha FH de Witte, Wichor M Bramer, Carla C Baan & Martin J Hoogduijn. (2015) Efficacy of immunotherapy with mesenchymal stem cells in man: a systematic review. Expert Review of Clinical Immunology 11:5, pages 617-636.
Read now

Articles from other publishers (19)

Stanley Chun Ming Wu, Manyu Zhu, Stanley C. C. Chik, Maxwell Kwok, Asif Javed, Laalaa Law, Shing Chan, Kenneth R. Boheler, Yin Ping Liu, Godfrey Chi Fung Chan & Ellen Ngar-Yun Poon. (2023) Adipose tissue-derived human mesenchymal stromal cells can better suppress complement lysis, engraft and inhibit acute graft-versus-host disease in mice. Stem Cell Research & Therapy 14:1.
Crossref
Hui-Yun Cheng, Madonna Rica Anggelia, Cheng-Hung Lin & Fu-Chan Wei. (2023) Toward transplantation tolerance with adipose tissue-derived therapeutics. Frontiers in Immunology 14.
Crossref
Željka Večerić-Haler, Matjaž Sever, Nika Kojc, Philip F. Halloran, Emanuela Boštjančič, Gregor Mlinšek, Manca Oblak, Primož Poženel, Urban Švajger, Katrina Hartman, Miomir Kneževič, Ariana Barlič, Lenart Girandon, Andreja Aleš Rigler, Samo Zver, Jadranka Buturović Ponikvar & Miha Arnol. (2022) Autologous Mesenchymal Stem Cells for Treatment of Chronic Active Antibody-Mediated Kidney Graft Rejection: Report of the Phase I/II Clinical Trial Case Series. Transplant International 35.
Crossref
Urvashi Kaundal, Raja Ramachandran, Amit Arora, Deepesh B. Kenwar, Ratti Ram Sharma, Ritambhra Nada, Mukut Minz, Vivekanand Jha & Aruna Rakha. (2022) Mesenchymal Stromal Cells Mediate Clinically Unpromising but Favourable Immune Responses in Kidney Transplant Patients. Stem Cells International 2022, pages 1-17.
Crossref
Gabriele Storti, Evaldo Favi, Francesca Albanesi, Bong-Sung Kim & Valerio Cervelli. (2021) Adipose-Derived Stem/Stromal Cells in Kidney Transplantation: Status Quo and Future Perspectives. International Journal of Molecular Sciences 22:20, pages 11188.
Crossref
Željka Večerić-Haler, Nika Kojc, Matjaž Sever, Samo Zver, Urban Švajger, Primož Poženel, Katrina Hartman, Tereza Urdih, Gregor Mlinšek, Manca Oblak, Andreja Aleš Rigler, Alojz Ihan, Jadranka Buturović Ponikvar, Philip P. Halloran & Miha Arnol. (2021) Case Report: Capillary Leak Syndrome With Kidney Transplant Failure Following Autologous Mesenchymal Stem Cell Therapy. Frontiers in Medicine 8.
Crossref
Shujun Lin, Wenshan Lin, Chunling Liao & Tianbiao Zhou. (2020) Nephroprotective Effect of Mesenchymal Stem Cell-Based Therapy of Kidney Disease Induced by Toxicants. Stem Cells International 2020, pages 1-12.
Crossref
Christopher J. Rogers, Robert J. Harman, Bruce A. Bunnell, Martin A. Schreiber, Charlie Xiang, Fu-Sheng Wang, Antonio F. Santidrian & Boris R. Minev. (2020) Rationale for the clinical use of adipose-derived mesenchymal stem cells for COVID-19 patients. Journal of Translational Medicine 18:1.
Crossref
Jordan R. Yaron, Jacek M. Kwiecien, Liqiang Zhang, Sriram Ambadapadi, Dara N. Wakefield, William L. Clapp, Wojciech Dabrowski, Michelle Burgin, Barbara H. Munk, Grant McFadden, Hao Chen & Alexandra R. Lucas. (2019) Modifying the Organ Matrix Pre-engraftment: A New Transplant Paradigm?. Trends in Molecular Medicine 25:7, pages 626-639.
Crossref
Loubna Mazini, Luc Rochette, Mohamed Amine & Gabriel Malka. (2019) Regenerative Capacity of Adipose Derived Stem Cells (ADSCs), Comparison with Mesenchymal Stem Cells (MSCs). International Journal of Molecular Sciences 20:10, pages 2523.
Crossref
Urvashi Kaundal, Upma Bagai & Aruna Rakha. (2018) Immunomodulatory plasticity of mesenchymal stem cells: a potential key to successful solid organ transplantation. Journal of Translational Medicine 16:1.
Crossref
Matthias Waldner, Wensheng Zhang, Isaac B. James, Kassandra Allbright, Emmanuelle Havis, Jacqueline M. Bliley, Aurora Almadori, Riccardo Schweizer, Jan A. Plock, Kia M. Washington, Vijay S. Gorantla, Mario G. Solari, Kacey G. Marra & J. Peter Rubin. (2018) Characteristics and Immunomodulating Functions of Adipose-Derived and Bone Marrow-Derived Mesenchymal Stem Cells Across Defined Human Leukocyte Antigen Barriers. Frontiers in Immunology 9.
Crossref
Pamina Contreras-Kallens, Claudia Terraza, Karina Oyarce, Tania Gajardo, Mauricio Campos-Mora, María Teresa Barroilhet, Carla Álvarez, Ricardo Fuentes, Fernando Figueroa, Maroun Khoury & Karina Pino-Lagos. (2018) Mesenchymal stem cells and their immunosuppressive role in transplantation tolerance. Annals of the New York Academy of Sciences 1417:1, pages 35-56.
Crossref
Navid Mohamadpour Toyserkani, Mads Gustaf Jørgensen, Siavosh Tabatabaeifar, Charlotte Harken Jensen, Søren Paludan Sheikh & Jens Ahm Sørensen. (2017) Concise Review: A Safety Assessment of Adipose-Derived Cell Therapy in Clinical Trials: A Systematic Review of Reported Adverse Events. Stem Cells Translational Medicine 6:9, pages 1786-1794.
Crossref
Sergio Dellepiane, Davide Medica, Alessandro Domenico Quercia & Vincenzo Cantaluppi. (2017) The exciting “bench to bedside” journey of cell therapies for acute kidney injury and renal transplantation. Journal of Nephrology 30:3, pages 319-336.
Crossref
Hargovind L. Trivedi & Aruna V. Vanikar. 2017. Regenerative Medicine: Laboratory to Clinic. Regenerative Medicine: Laboratory to Clinic 409 421 .
Cheng Chen & Jianquan Hou. (2016) Mesenchymal stem cell-based therapy in kidney transplantation. Stem Cell Research & Therapy 7:1.
Crossref
Ernesto Balolong, Soojung Lee, Judee Grace Nemeno & Jeong Ik Lee. (2016) Are They Really Stem Cells? Scrutinizing the Identity of Cells and the Quality of Reporting in the Use of Adipose Tissue-Derived Stem Cells. Stem Cells International 2016, pages 1-11.
Crossref
Riccardo Schweizer, Vijay S. Gorantla & Jan A. Plock. (2015) Premise and promise of mesenchymal stem cell-based therapies in clinical vascularized composite allotransplantation. Current Opinion in Organ Transplantation 20:6, pages 608-614.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.